Research Snappy
  • Market Research Forum
  • Investment Research
  • Consumer Research
  • More
    • Advertising Research
    • Healthcare Research
    • Data Analysis
    • Top Companies
    • Latest News
No Result
View All Result
Research Snappy
No Result
View All Result

Los Angeles Capital Management & Equity Research Inc. Makes New $5.20 Million Investment in Healthpeak Properties (NASDAQ:PEAK)

researchsnappy by researchsnappy
February 23, 2020
in Investment Research
0
SalMar ASA (OTCMKTS:SALRF) Rating Increased to Hold at Nordea Equity Research
399
SHARES
2.3k
VIEWS
Share on FacebookShare on Twitter

Healthpeak Properties logoLos Angeles Capital Management & Equity Research Inc. bought a new position in shares of Healthpeak Properties (NASDAQ:PEAK) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 150,852 shares of the company’s stock, valued at approximately $5,200,000.

Several other large investors also recently bought and sold shares of the business. State Street Corp purchased a new stake in shares of Healthpeak Properties during the fourth quarter worth $1,204,659,000. Resolution Capital Ltd purchased a new stake in shares of Healthpeak Properties during the fourth quarter worth $341,784,000. PGGM Investments purchased a new stake in shares of Healthpeak Properties during the fourth quarter worth $320,756,000. Principal Financial Group Inc. purchased a new stake in shares of Healthpeak Properties during the fourth quarter worth $316,567,000. Finally, Charles Schwab Investment Management Inc. purchased a new stake in shares of Healthpeak Properties during the fourth quarter worth $227,489,000.

Several equities research analysts have issued reports on PEAK shares. Mizuho restated a “buy” rating and set a $38.00 target price on shares of Healthpeak Properties in a research report on Wednesday, February 12th. BMO Capital Markets restated a “buy” rating and set a $38.00 target price on shares of Healthpeak Properties in a research report on Thursday, February 13th.

Healthpeak Properties stock opened at $37.15 on Friday. Healthpeak Properties has a fifty-two week low of $28.86 and a fifty-two week high of $37.93. The stock has a fifty day moving average price of $36.17.

Healthpeak Properties (NASDAQ:PEAK) last released its quarterly earnings results on Tuesday, February 11th. The company reported $0.09 earnings per share for the quarter, missing the consensus estimate of $0.44 by ($0.35). The firm had revenue of $531.69 million for the quarter, compared to analysts’ expectations of $540.80 million.

The company also recently declared a quarterly dividend, which will be paid on Friday, February 28th. Stockholders of record on Tuesday, February 18th will be issued a $0.37 dividend. The ex-dividend date of this dividend is Friday, February 14th. This represents a $1.48 annualized dividend and a dividend yield of 3.98%.

Healthpeak Properties Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns and develops high-quality real estate in the three private-pay healthcare asset classes of Life Science, Senior Housing and Medical Office, designed to provide stability through the inevitable industry cycles.

Featured Story: How prevalent are 12b-1 fees?

Want to see what other hedge funds are holding PEAK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Healthpeak Properties (NASDAQ:PEAK).

Institutional Ownership by Quarter for Healthpeak Properties (NASDAQ:PEAK)



Receive News & Ratings for Healthpeak Properties Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Healthpeak Properties and related companies with MarketBeat.com’s FREE daily email newsletter.

Previous Post

‘There’s no demographic’: founder of men’s make-up brand War Paint declares victory | Business

Next Post

Cardano (ADA) Price Analysis (February 23)

Next Post
Cardano (ADA) Price Analysis (February 23)

Cardano (ADA) Price Analysis (February 23)

Research Snappy

Category

  • Advertising Research
  • Consumer Research
  • Data Analysis
  • Healthcare Research
  • Investment Research
  • News

Pa. Republicans reconsider Pitt funding over fetal tissue research, college voucher program

Arthur Pharma Closes Series A Financing Round

YouTube and the Achilles Tendon: An Analysis of Internet Information Reliability and Content Quality

  • Privacy Policy
  • Terms of Use
  • Antispam
  • DMCA
  • Contact Us

© 2022 researchsnappy.com

No Result
View All Result
  • Market Research Forum
  • Investment Research
  • Consumer Research
  • More
    • Advertising Research
    • Healthcare Research
    • Data Analysis
    • Top Companies
    • Latest News

© 2022 researchsnappy.com